EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Myelin Basic Protein in Oligodendrocyte-Derived Extracellular Vesicles as a Diagnostic and Prognostic Biomarker in Multiple Sclerosis: A Pilot Study

Cristina Agliardi iD, Franca Rosa Guerini iD, Milena Zanzottera, Elisabetta Bolognesi iD, Silvia Picciolini iD, Domenico Caputo, Marco Rovaris, Maria Barbara Pasanisi, Mario Clerici

International Journal of Molecular Sciences · 03.01.2023 · 24 (1) · 894

DOI: 10.3390/ijms24010894 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.01.2023. Verfasst von Cristina Agliardi und 8 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Fondazione Don Carlo Gnocchi, 20147 Milan, Italy. Hauptthemen laut MEDLINE: Extracellular Vesicles, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Relapsing-Remitting, Myelin Basic Protein. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Governo Italiano: Ricerca Corrente, Fondazione Alessandro e Vincenzo Negroni Prati Morosini, Fondazione Romeo ed Enrica Invernizzi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Approximately 15% of multiple sclerosis (MS) patients develop a progressive form of disease from onset; this condition (primary progressive-PP) MS is difficult to diagnose and treat, and is associated with a poor prognosis. Extracellular vesicles (EVs) of brain origin isolated from blood and their protein cargoes could function as a biomarker of pathological conditions. We verified whether MBP and MOG content in oligodendrocytes-derived EVs (ODEVs) could be biomarkers of MS and could help in the differential diagnosis of clinical MS phenotypes. A total of 136 individuals (7 clinically isolated syndrome (CIS), 18 PPMS, 49 relapsing remitting (RRMS)) and 70 matched healthy controls (HC) were enrolled. ODEVs were enriched from serum by immune-capture with anti-MOG antibody; MBP and MOG protein cargoes were measured by ELISA. MBP concentration in ODEVs was significantly increased in CIS (p < 0.001), RRMS (p < 0.001) and PPMS (p < 0.001) compared to HC and was correlated with disease severity measured by EDSS and MSSS. Notably, MBP concentration in ODEVs was also significantly augmented in PPMS compared to RRMS (p = 0.004) and CIS (p = 0.03). Logistic regression and ROC analyses confirmed these results. A minimally invasive blood test measuring the concentration of MBP in ODEVs is a promising tool that could facilitate MS diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesMultiple Sclerosis, Chronic ProgressiveMultiple Sclerosis, Relapsing-RemittingMyelin Basic ProteinHumansBiomarkersMyelin-Oligodendrocyte GlycoproteinOligodendrogliaPilot ProjectsPrognosis

Stichwörter der Autor:innen

MBPMOGbiomarkersexosomesextracellular vesiclesmultiple sclerosisoligodendrocytesprimary progressive multiple sclerosis

Substanzen

BiomarkersMyelin Basic ProteinMyelin-Oligodendrocyte Glycoprotein

Autor:innen und Institutionen

  • IRCCS Fondazione Don Carlo Gnocchi, 20147 Milan, Italy.
  • Pathophysiology and Transplantation Department, University of Milan, 20122 Milan, Italy.

ORCID-Profile: Cristina Agliardi, Franca Rosa Guerini, Elisabetta Bolognesi, Silvia Picciolini

Förderung

  • Governo Italiano: Ricerca Corrente
  • Fondazione Alessandro e Vincenzo Negroni Prati Morosini
  • Fondazione Romeo ed Enrica Invernizzi
  • Italian Ministry of Health

Zitieren

APA

Agliardi, C., Guerini, F. R., Zanzottera, M., Bolognesi, E., Picciolini, S., Caputo, D., Rovaris, M., Pasanisi, M. B., & Clerici, M. (2023). Myelin Basic Protein in Oligodendrocyte-Derived Extracellular Vesicles as a Diagnostic and Prognostic Biomarker in Multiple Sclerosis: A Pilot Study. International Journal of Molecular Sciences, 24(1), 894. https://doi.org/10.3390/ijms24010894

Vancouver

Agliardi C, Guerini FR, Zanzottera M, Bolognesi E, Picciolini S, Caputo D, et al. Myelin Basic Protein in Oligodendrocyte-Derived Extracellular Vesicles as a Diagnostic and Prognostic Biomarker in Multiple Sclerosis: A Pilot Study. International Journal of Molecular Sciences. 2023;24(1):894. doi:10.3390/ijms24010894

BibTeX
@article{Agliardi2023,
  author = {Agliardi, Cristina and Guerini, Franca Rosa and Zanzottera, Milena and Bolognesi, Elisabetta and Picciolini, Silvia and Caputo, Domenico and Rovaris, Marco and Pasanisi, Maria Barbara and Clerici, Mario},
  title = {Myelin Basic Protein in Oligodendrocyte-Derived Extracellular Vesicles as a Diagnostic and Prognostic Biomarker in Multiple Sclerosis: A Pilot Study},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {1},
  pages = {894},
  doi = {10.3390/ijms24010894}
}
Kostenlos starten →